본문 바로가기
KERD
논문KCI 등재

정상대장점막, 샘종 및 대장암 병소에서 pS2/TFF1 단백발현에 관한 연구

Expression of pS2/TFF1 Protein in Normal Colonic Mucosa, Adenoma and Adenocarcinoma

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : The trefoil factor 1 protein (pS2/TFF1) is a candidate tumor-suppressor protein, and it is a pleiotropic factor involved in the organization and homeostasis of the gastrointestinal tract and various inflammatory or neoplastic diseases. The purpose of this study was to assess the expression of pS2/TFF1 and its clinicopathologic relationship, including the p53 and Ki-67 labeling index, in colorectal carcinogenesis. Methods : The expression of pS2/TFF1 protein was evaluated immunohistochemically in 45 samples of normal colonic mucosa, 43 samples of adenoma and 186 samples of colorectal carcinoma. Results : pS2/TFF1 protein was expressed weakly in 37.8% of normal colonic mucosa samples, and it had a weak to strong expression in 48.8% of adenomas and 28% of colorectal adenocarcinomas. pS2/ TFF1 expression in carcinoma was slightly increased in the poorly differentiated group compared with the well to moderately differentiated group (p=0.059). Interestingly, mucinous carcinoma (4/4) and signet ring cell carcinoma (2/3) showed significant increase of pS2/TFF1 expression. pS2/TFF1 expression was inversely correlated with the p53 protein expression and the Ki-67 labelling index (p<0.05). There was no significant correlation with the tumor size, metastasis or pathologic staging. Conclusions : Overexpression of pS2/TFF1 expression in colorectal adenocarcinoma was inversely correlated with the Ki-67 labelling index and the p53 expression in cancer. These results suggest that pS2/TFF1 protein may contribute as tumor suppressor factor in colorectal adenocarcinoma.

참고문헌 (27)

  1. "Trefoil factors: initiators of mucosal healing.", 4, pp.721~732 (2003)
  2. "Trefoil peptides and surgicaldisease.", 86, pp.740~748 (1999)
  3. "Trefoil peptides.", 44, pp.890~895 (1999)
  4. "Cloning of cDNA sequences of hormone-regulated genesfrom the MCF-7 human breast cancer cell line.", pp.7895~903
  5. "Goblet cell-specific expression of apeptide targeted for apical secretion", pp.6694~702
  6. "pS2 expression as a possiblediagnostic marker of colorectal carcinoma in ulcerative colitis.", 7, pp.233~239 (2000)
  7. "Multiple ‘serrated adenocarcinomas’ of the colon with a cell lineagecommon to metaplastic polyp and serrated adenoma Casereport of a new subtype of colonic adenocarcinoma with gastricdifferentiation.", 190, pp.444~449 (2000)
  8. "Conserved expression ofintestinal trefoil factor in the human colonic adenoma-carcinomasequence.", 75, pp.25~32 (1996)
  9. "Differentialexpression of oestrogen receptor and oestrogen induciblegenes in gastric mucosa and cancer.", 40, pp.516~520 (1997)
  10. "Breast cancer-associatedprotein pS2 expression in tumors of the biliary tract", pp.1491~4
  11. "Association of the human spasmolyticpolypeptide and an estrogen-induced breast cancer protein"
  12. "Intestinal trefoil factor (TFF 3) and pS2 (TFF 1) but not spasmolyticpolypeptide (TFF 2) mRNAs are co-expressed in normal,hyperplastic, and neoplastic human breast epithelium.", pp.30~38 (1997)
  13. "Differential expressionof the pS2 protein in the human prostate and prostate cancer association with premalignant changes and neuroendocrine differentiation", 26, pp.824~828 (1995)
  14. "Gastric mucosa abnormalitiesand tumorigenesis in mice lacking the pS2 trefoil protein,", 274, pp.259~262 (1996)
  15. "Coordinatelate expression of trefoil peptide genes (pS2", TFF1 and ITF, pp.2002, 1[DOI]
  16. "The pS2protein in colorectal carcinomas and metastases.", 194, pp.171~176 (1998)
  17. "pS2 immunostaining of colorectal carcinoma", sanni(p), pp.446~8
  18. "Expression of pS2 protein in transitionalcell bladder tumours", pp.327~32
  19. "Specific expression of the pS2gene in subclasses of breast cancers in comparison with expressionof the estrogen and progesterone receptors and the oncogene ERBB2", pp.9243~7
  20. "pS2 expression andresponse to hormonal therapy in patients with advanced breastcancer", pp.624~8
  21. "Up-regulation ofpS2 expression during the development of adenocarcinomas butnot squamous cell carcinomas of the uterine cervix independentlyof expression of c-jun or oestrogen and progesterone receptors", 190, pp.554~563 (2000)
  22. "Expression of estrogenreceptor subtypes and ERbeta isoforms in colon cancer.", 61, pp.632~640 (2001)
  23. "genomic organization, sequences and methylation analyses.", 266, pp.67~75 (2001)
  24. "Loss of heterozygosity andpromoter methylation may underlie loss of TFF1in gastric carcinoma.", 82, pp.1319~1326 (2002)
  25. "Are there two sides to colorectal cancer?", 101, pp.403~408 (2002)
  26. "Overexpressionof intestinal trefoil factor in human colon carcinoma cells reducescellular growth in vitro and in vivo.", 118, pp.60~69 (2000)
  27. "The trefoil peptide TFF1 inhibits the growth of the humangastric adenocarcinoma cell line AGS.", 188, pp.312~317

관련 논문AI추천

대장암 환자에서 선암종과 선종성 용종의 Leptin 발현손원, 백승삼, 백유흠, 윤병철, 이강녕, 이동후, 이상표, 이오영, 이학현, 이항락, 장기석, 전대원, 최호순대한내과학회 · 대한내과학회지2007 · 제72권 제4호대장의 샘종 및 샘암종에서 Osteopontin, ZO-1 및 E-cadherin의 발현기근홍, 서재홍, 이미자, 임성철, 전호종, 정유경대한병리학회 · Journal of Pathology and Translational Medicine2005 · 제39권 제4호대장 선종 및 대장 선암에서 TGF-β1, 제2형 TGF-β 수용체 및 VEGF 단백의 면역조직화학적 발현강상범, 김연수, 김진만, 남순우, 이동수, 이승우, 최규용, 한석원대한소화기내시경학회 · Clinical Endoscopy2007 · 제35권 제5호대장의 관상샘종 및 관상샘암종에서의 Melanoma Antigen Gene A1-6의 발현구자영, 박무인, 박진경, 박희승, 엄정섭, 장희경, 정민정대한소화기내시경학회 · Clinical Endoscopy2003 · 제27권 제6호대장 종양에서 CD43의 발현에 관한 연구김우진, 김혜은, 노혜린, 박원서, 배영미, 안혜경, 장명철, 정경천, 채기봉, 최원진대한병리학회 · Journal of Pathology and Translational Medicine2004 · 제38권 제1호위암에서 예후인자로서 점액소 표현형과 CDX2 단백 발현의 역할박경신, 박조현, 송교영, 이교영, 정찬권, 최명규, 홍영선대한병리학회 · Journal of Pathology and Translational Medicine2007 · 제41권 제3호

이 간행물의 다른 논문 (13건)